Q: Your practice is one of the first to have the LenSx femtosecond laser from Alcon. Can you explain its potential? Kerry Solomon: This equipment helps surgeons correct astigmatism in cataract surgery ...

Alcon’s LenSx femtosecond laser may be the most significant piece of technology to impact cataract surgery in recent years, allowing surgeons to correct astigmatism in cataract patients by creating ...

HUENENBERG, Switzerland--(BUSINESS WIRE)--Alcon, Inc. (NYSE: ACL) announced today that it has entered into a definitive agreement to acquire LenSx Lasers, Inc, a privately held company that developed ...

SAN DIEGO — Refractive outcomes and the difference in best corrected visual acuity in patients treated with conventional cataract surgery are not significantly different than those in patients treated ...

Alcon Inc., an eye care company with more than 770 workers in Irvine, said it is buying Aliso Viejo startup LenSx Lasers Inc. for $362 million. LenSx, a venture capital-backed company, makes lasers ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. HUENENBERG, Switzerland — Alcon has completed its ...

Huge return for venture capitalists as acquisition by Alcon Laboratories shows value of femtosecond lasers for cataract surgery. The acquisition of medical laser systems specialist LenSx Lasers by ...

Please log in, or sign up for a new account and purchase a subscription to continue reading. BEST VALUE! Like never before, the Daily News delivers real value every ...

The U.S. Food and Drug Administration has cleared Alcon’s LenSx laser platform for creating corneal flaps in refractive surgical procedures, according to a press release. The new functionality will ...

Eye-care company Alcon said today it has agreed to acquire privately held cataract surgery developer LenSx Lasers. Alcon will pay $361.5 million in cash, as well as $382.5 million in contingent ...